Company
United StatesPublic company, NASDAQ: MCRBSeres Therapeutics, Inc. (NASDAQ: MCRB), Waltham, MA – FDA Inspections
Inspection records and compliance data for Seres Therapeutics, Inc. in Waltham, Massachusetts. 2 FDA inspections on record, last inspected July 25, 2025. Publicly traded as NASDAQ: MCRB.
Company Profile
This profile covers Seres Therapeutics, Inc. based in Waltham, Massachusetts, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected December 9, 2022. Last inspected July 25, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 25, 2025 | NAI | Biologics · Vaccines and Allergenic Products | 1276673 |
| December 9, 2022 | NAI | Biologics · Vaccines and Allergenic Products | 1202299 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Seres Therapeutics, Inc.
Stock ticker
MCRB
Exchange
NASDAQ
Share price
$2.09
Market cap
$21.3M
Price as of
November 6, 2026
FEI Number
3021578714
Address
9 4th Ave, Waltham, Massachusetts 02451, United States
Country
United States
ID: 1ea165f0-3cbb-477f-be05-755a851dd0c8